GERMANY - High-Tech Gründerfonds backs start-up Immunservice

High-Tech Gründerfonds has provided seed financing for Immunservice GmbH, a start-up which develops immune biomimetic hormones for drug testing. The seed financing enables the company to optimise production of its lead product Pulmoleukin to industrial scale and to prepare the approval process of the drug. In addition to the seed funding, the company received grants, and more capital will be raised in a further funding round that has already attracted interest from international co-investors.